DOI:
10.1055/s-00042120
International Journal of Recent Surgical and Medical Sciences
LinksClose Window
References
McComsey GA, Kitch D, Daar ES. et al.
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.
J Infect Dis 2011;
203 (12) 1791-1801
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.